BCAL Diagnostics (ASX:BDX) Total Liabilities: A$4.68 Mil (As of Dec. 2025)


What is BCAL Diagnostics Total Liabilities?

BCAL Diagnostics ASX:BDX +1.41% Total Liabilities is A$4.68 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

BCAL Diagnostics's Total Liabilities for the quarter that ended in Dec. 2025 was A$4.68 Mil.

BCAL Diagnostics's quarterly Total Liabilities increased from Dec. 2024 (A$2.12 Mil) to Jun. 2025 (A$3.69 Mil) and increased from Jun. 2025 (A$3.69 Mil) to Dec. 2025 (A$4.68 Mil).

BCAL Diagnostics's annual Total Liabilities increased from Jun. 2023 (A$3.16 Mil) to Jun. 2024 (A$3.68 Mil) and increased from Jun. 2024 (A$3.68 Mil) to Jun. 2025 (A$3.69 Mil).

BCAL Diagnostics Total Liabilities Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics Total Liabilities Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Total Liabilities
0.95 3.16 3.68 3.69

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.36 3.68 2.12 3.69 4.68

BCAL Diagnostics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BCAL Diagnostics's Total Liabilities for the fiscal year that ended in Jun. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.108+(0.58+1.1102230246252E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=3.69

Total Liabilities=Total Assets (A: Jun. 2025 )-Total Equity (A: Jun. 2025 )
=9.909-6.221
=3.69

BCAL Diagnostics's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.302+(2.976+0.397
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=4.68

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=7.173-2.498
=4.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of A$4.68 Mil mean?
BCAL Diagnostics (ASX:BDX) has a Total Liabilities of A$4.68 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BCAL Diagnostics and its competitors.
Is BCAL Diagnostics' Total Liabilities too high?
BCAL Diagnostics' current Total Liabilities is A$4.68 Mil.
How does BCAL Diagnostics' Total Liabilities compare to TMO and DHR?
BCAL Diagnostics' Total Liabilities of A$4.68 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for BCAL Diagnostics and its competitors. BCAL Diagnostics's current Total Liabilities is A$4.68 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current Total Liabilities of A$4.68 Mil. The current Total Liabilities is A$4.68 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current Total Liabilities is A$4.68 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.